[Initial results with Ro 6-4793-1 in malaria].
D000962:Antimalarials / Q000627:therapeutic use*; D006801:Humans; D008288:Malaria / Q000188:drug therapy*; D010961:Plasmodium / Q000187:drug effects; D011739:Pyrimethamine / Q000627:therapeutic use; D013424:Sulfanilamides / Q000627:therapeutic use
D000962:Antimalarials; D013424:Sulfanilamides; D011739:Pyrimethamine
Resultados iniciais com o Ro 6-4793-1 em malária.